Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $118.32 | $24.56 | 381.68% | 223.25x | 202.81x | 15.01x | 18.12x | 1.73x | $106.92M | 0.86% | $705.78M | 6.70 | $12.69B | 1,617.41 | ||
| LQDA | LIQUIDIA CORP | $86.80 | $17.08 | 408.28% | 361.67x | 26.12x | 26.52x | 71.09x | 1.75x | $41.15M | 0.54% | $108.58M | 1.23 | $7.68B | 143.32 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $205.48 | $89.64 | 129.22% | 47.13x | 28.36x | 6.37x | 25.51x | 0.97x | $641.34M | 2.35% | $1.08B | 8.09 | $28.69B | 31.04 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.42 | $2.69 | 213.23% | 120.29x | 75.04x | 4.56x | 111.72x | 1.15x | $47.52M | 3.31% | $13.01M | 0.08 | $1.60B | 29.95 | ||
| HALO | HALOZYME THERAPEUTICS INC | $83.30 | $67.80 | 22.86% | 28.14x | 10.04x | 6.52x | 44.99x | 0.50x | $667.65M | 6.78% | $219.64M | 1.86 | $11.71B | 18.78 | ||
| VCEL | VERICEL CORP | $47.61 | $8.70 | 447.06% | 110.72x | 98.76x | 8.28x | 6.83x | 2.33x | $47.49M | 1.96% | $356.23M | 7.02 | $2.42B | 59.79 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.58 | $37.38 | 62.06% | 43.27x | 16.31x | 3.60x | 1.88x | 0.64x | $767.06M | 6.58% | $6.21B | 32.27 | $10.07B | 20.86 | ||
| ASND | ASCENDIS PHARMA A | $251.07 | $76.32 | 228.98% | 26.61x | 17.26x | 15.31x | 27.16x | 2.77x | $52.94M | 0.34% | $574.09M | 9.24 | $15.98B | 171.31 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.20 | $16.44 | 375.67% | 73.08x | 62.11x | 7.21x | 9.33x | 2.26x | $182.84M | 3.01% | $654.15M | 8.43 | $5.93B | 49.47 | ||
| RPRX | ROYALTY PHARMA PLC | $59.02 | $38.69 | 52.55% | 30.90x | 11.00x | 10.56x | 3.42x | 0.65x | $2.34B | 9.08% | $9.94B | 22.75 | $42.36B | 36.41 | ||
| KRYS | KRYSTAL BIOTECH INC | $366.85 | $87.36 | 319.94% | 47.34x | 48.10x | 25.75x | 8.47x | 2.42x | $237.38M | 2.21% | $1.28B | 43.59 | $10.32B | 48.25 | ||
| ADMA | ADMA BIOLOGICS INC | $8.67 | $8.77 | -1.09% | 12.57x | 10.33x | 4.01x | 5.15x | 0.52x | $107.90M | 5.27% | $390.33M | 1.65 | $2.07B | 9.34 | ||
| TGTX | TG THERAPEUTICS INC | $53.53 | $23.32 | 129.59% | 16.62x | 37.99x | 11.04x | 14.05x | 2.39x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.50B | 56.68 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $258.38 | $46.94 | 450.43% | 549.74x | 10.01x | 3.60x | 3.58x | 1.86x | $1.30B | 8.11% | $4.53B | 73.22 | $19.77B | 29.29 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.86 | $33.50 | 7.05% | 14.17x | 9.45x | 2.31x | 2.28x | 0.55x | $341.79M | 16.48% | $910.35M | 15.75 | $1.65B | 6.94 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $296.29 | $97.48 | 203.94% | 37.51x | 32.06x | 21.46x | 5.95x | 1.64x | $122.22M | 2.07% | $997.32M | 50.16 | $6.27B | 27.82 | ||
| TECH | BIO-TECHNE CORP | $72.03 | $15.95 | 351.46% | 101.45x | 34.52x | 9.30x | 5.41x | 1.86x | $269.60M | 2.39% | $2.09B | 13.34 | $11.36B | 44.37 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $8.55 | -85.97% | 4.44x | -4.06x | 1.12x | 1.31x | 0.05x | $7.24M | 10.50% | $52.93M | 0.92 | $15.83M | 1.02 | ||
| UTHR | UNITED THERAPEUTICS CORP | $525.82 | $227.38 | 131.25% | 17.96x | 19.21x | 7.22x | 3.78x | 2.09x | $1.02B | 4.45% | $5.90B | 135.66 | $21.04B | 12.28 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.32 | $1.96 | 69.75% | 13.83x | 14.36x | 2.03x | 3.21x | 1.41x | $4.11M | 1.54% | $82.33M | 1.03 | $200.45M | 9.44 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $481.70 | $158.05 | 204.77% | 28.32x | 24.91x | 10.02x | 6.31x | 2.12x | $3.71B | 3.03% | $19.36B | 76.20 | $118.75B | 22.02 | ||
| EXEL | EXELIXIS INC | $55.97 | $28.95 | 93.36% | 17.94x | 17.39x | 6.09x | 7.27x | 1.35x | $917.69M | 6.35% | $1.94B | 7.49 | $14.01B | 13.27 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $738.34 | $414.97 | 77.93% | 17.60x | 15.81x | 4.89x | 2.40x | 1.16x | $3.76B | 4.95% | $31.71B | 308.48 | $76.27B | 13.26 | ||
| VCYT | VERACYTE INC | $59.78 | $8.59 | 596.07% | 53.86x | 53.91x | 8.78x | 3.55x | 6.34x | $155.34M | 3.27% | $1.34B | 16.90 | $4.54B | 39.50 | ||
| INCY | INCYTE CORP | $122.99 | $60.18 | 104.36% | 15.15x | 16.18x | 4.23x | 3.93x | 2.03x | $1.92B | 7.79% | $6.34B | 31.66 | $20.98B | 10.14 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.